期刊文献+

吡嘧司特钾水凝胶骨架缓释片的研究 被引量:2

The study on hydrophilic gel matrix sustained-release tablets of pemirolast potassium
下载PDF
导出
摘要 目的 :研制吡嘧司特钾 (TBX)水凝胶缓释骨架片。方法 :以羟丙甲基纤维素 (HPMC)为骨架材料 ,考察HPMC用量、黏度及压片压力等对主药体外释放速度的影响 ,优化处方工艺。结果 :所得片剂体外释放实验表明10h累积释放度 >75 % ,其释放行为符合Higuchi方程。HPMC的用量、黏度、制备方法及压片片力的大小等对TBX的释放速率均有显著影响。结论 :用高黏度的HPMC作为亲水凝胶骨架片的基质能达到较好的缓释作用。 Objective:To prepare HPMC hydrophilic gel matrix tablets containing pemirolast potassium(TBX) as a sustained-release preparations.Methods:The effects of the amount and viscosity of hydroxyopyll-methlcellulose(HPMC),compressing pressure and additives on the drug release from the matrix tables were observed.Results:Those factors can influence the release of TBX from HPMC hydrophilic matrix tablets.The accumulated release amount of TBX sustained tablet was more than 75% within 10 hours.The drug release pattern was in accord ance with the Higuchi equation.Conclusion:The higher viscosity HPMC matrix tablets of TBX can be used as a barrier to prepare a matrix sustained-release tablet of TBX.
机构地区 中南大学药学院
出处 《中国新药杂志》 CAS CSCD 北大核心 2003年第8期632-635,共4页 Chinese Journal of New Drugs
关键词 吡嘧司特钾 缓释片 羟丙甲基纤维素 药物释放度 pemirolast potassium sustained-release tablets hydroxyopyl-methylcellulose releasing rate
  • 相关文献

参考文献7

  • 1陈挺,陈子晟,包泳初,陈庆华.国产HPMC作为盐酸普萘洛尔缓释骨架片基质的研究[J].中国医药工业杂志,1998,29(1):10-16. 被引量:17
  • 2施佩君.抗过敏药 pemirolast potassiam[J].国外医药—合成药、生化药、制剂分册,1993,14(2):114-115.
  • 3付桂英,李三鸣,王齐放,王岩,马春娟.磷酸苯丙哌林亲水凝胶缓释片的制备[J].沈阳药科大学学报,2000,17(5):321-323. 被引量:2
  • 4.[P]...
  • 5Takifima T,Tamura G,Taniguchi S, et al .Clinical evaluation of TBX, an oral anfiallergic agent, in tablet form, over a prolonged period of time to adults with bronchial asthma[J]. Med Consult New Rern, 1989,26(7) :29-48.
  • 6Miholce K.Plasma level and urine excretion in human aftex administration of TBX[J] .Jpm Pharmacool Ther, 1990,18(3):1035-1040.
  • 7Yazaki T, Taguma K, Oguchi M.Studies on sustainded-release. preparation[P] .JP. 特開平,4-368,330.1992-12-21.

二级参考文献5

  • 1董志超,蒋雪涛.羟丙基甲基纤维素的性质对药物亲水性骨架片溶出度的影响[J].药学学报,1994,29(12):920-924. 被引量:61
  • 21,Yamatsu K,Ohtsu K,Kase Y,et al.,The site of antitussive action of 1-(2-benzylphenoxy-2-piperidinopropane phosphate.Japanese J Pharm,1967,17:538~549
  • 32,Boton S.Pharmaceutical statistics.New York:Macel Dekker Inc,1984.273~275
  • 43,Boton S.Pharmaceutical statistics.New York:Macel Dekker Inc,1984.258~280
  • 54,Rigter P L,Peppas N A.A simple equation for description of solute release.Ⅱ.Fickian and anomalous release from swellable devices.J Controll Rel,1987,5:37~42

共引文献17

同被引文献35

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部